Nanjing Leads Biolabs Co Ltd
Status: Publicly traded
Direct answer
Nanjing Leads Biolabs Co Ltd is publicly traded on HKSE under the ticker 9887.HK.
Nanjing Leads Biolabs Co., Ltd. is a biotechnology firm currently in the clinical development phase, dedicated to the global discovery, progression, and eventual market launch of innovative antibody-based medications. The company's therapeutic endeavors concentrate on various critical illnesses, including cancerous growths, autoimmune disorders, and other serious medical conditions. A prominent product in its...
Can you invest in Nanjing Leads Biolabs Co Ltd?
Yes. Nanjing Leads Biolabs Co Ltd is publicly traded on HKSE under the ticker 9887.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nanjing Leads Biolabs Co Ltd
Detailed equity research is provided by MarketSnap.